These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 9125636

  • 1. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K.
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [Abstract] [Full Text] [Related]

  • 2. Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs.
    Sasaki N, Matsuno K, Okabe S.
    Aliment Pharmacol Ther; 2000 Apr; 14(4):479-88. PubMed ID: 10759628
    [Abstract] [Full Text] [Related]

  • 3. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [Abstract] [Full Text] [Related]

  • 4. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A, Miyata K, Tsutsumi R, Yuki H, Akuzawa S, Kobayashi A, Kamato T, Ito H, Yamano M, Katuyama Y.
    J Pharmacol Exp Ther; 1994 May 31; 269(2):725-31. PubMed ID: 7910212
    [Abstract] [Full Text] [Related]

  • 6. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.
    Takemoto Y, Yuki H, Nishida A, Ito H, Kobayashi-Uchida A, Takinami Y, Akuzawa S, Ohta M, Satoh M, Semple G, Miyata K.
    Arzneimittelforschung; 1998 Apr 31; 48(4):403-7. PubMed ID: 9608884
    [Abstract] [Full Text] [Related]

  • 7. Role of cholecystokinin in the intestinal fat- and acid-induced inhibition of gastric secretion.
    Konturek SJ, Bilski J, Cieszkowski M.
    Regul Pept; 1992 Nov 20; 42(1-2):97-109. PubMed ID: 1475410
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological analysis of wine-stimulated gastric acid secretion in dogs.
    Tsukimi Y, Ogawa T, Okabe S.
    J Physiol Paris; 2001 Nov 20; 95(1-6):221-8. PubMed ID: 11595441
    [Abstract] [Full Text] [Related]

  • 9. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S, Moizo L, Laigneau JP, Alchepo B, Lewin MJ, Bado A.
    Fundam Clin Pharmacol; 1998 Nov 20; 12(3):256-62. PubMed ID: 9646057
    [Abstract] [Full Text] [Related]

  • 10. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
    Nishida A, Yuki H, Tsutsumi R, Miyata K, Kamato T, Ito H, Yamano M, Honda K.
    Jpn J Pharmacol; 1992 Feb 20; 58(2):137-45. PubMed ID: 1354760
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
    Kuno M, Sogabe H, Ito H, Matsuo T, Satoh Y, Motoyama Y, Tanaka H.
    Pancreas; 1998 Jul 20; 17(1):57-64. PubMed ID: 9667521
    [Abstract] [Full Text] [Related]

  • 12. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats.
    Varga G, Campbell DR, Bussjaeger LJ, Solomon TE.
    Eur J Pharmacol; 1993 Nov 30; 250(1):37-42. PubMed ID: 8119323
    [Abstract] [Full Text] [Related]

  • 13. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Dec 30; 79(6):324-30. PubMed ID: 9000260
    [Abstract] [Full Text] [Related]

  • 14. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 15. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ, Harding M, Lloyd SA, McKnight AT, Hughes J, Woodruff GN.
    Br J Pharmacol; 1991 Dec 12; 104(4):973-7. PubMed ID: 1687371
    [Abstract] [Full Text] [Related]

  • 16. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M, Norlén P, Ding XQ, Nakamura S, Håkanson R.
    Br J Pharmacol; 2000 Jun 12; 130(3):699-705. PubMed ID: 10821801
    [Abstract] [Full Text] [Related]

  • 17. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M, Kondoh Y, Okamoto Y, Nishida A, Miyata K, Ohta M, Mase T, Murase K.
    Chem Pharm Bull (Tokyo); 1995 Dec 12; 43(12):2159-67. PubMed ID: 8582018
    [Abstract] [Full Text] [Related]

  • 18. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C, Lazzeri G, Colucci R, Carignani D, Tognetti M, Baschiera F, Del Tacca M.
    Eur J Pharmacol; 1999 May 28; 373(1):71-84. PubMed ID: 10408253
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
    Hills DM, Gerskowitch VP, Roberts SP, Welsh NJ, Shankley NP, Black JW.
    Br J Pharmacol; 1996 Dec 28; 119(7):1401-10. PubMed ID: 8968549
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.